Ling Zhang

15PUBLICATIONS
130CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 03, 2026
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.

|Jul 29, 2026
Clinical and Genomic Convergence of High-Risk CCUS and Lower-Risk Myelodysplastic Syndromes/Neoplasms.

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Feb 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study.

Amy E DeZern, Nancy Gillis, Michael Otterstatter

|Jan 28, 2026
Moving Beyond Somatic Alterations: Uncovering the Germline Basis of Myeloid Malignancies.

Ismail Elbaz Younes, Lynh Nguyen, Ling Zhang

|Nov 26, 2025
Cell State Transitions Drive the Evolution of Disease Progression in B-Lymphoblastic Leukemia.

Curtis Gravenmier, Sadegh Marzban, Yi-Han Tang

Pageof 3

Frequent Collaborators

7 joint publications

Rami S Komrokji

4 joint publications

Nancy Gillis

4 joint publications

David Sallman

3 joint publications

Michael Otterstatter